CRA assisted counsel in defending against state Consumer Protection Act allegations regarding sales of consumer health product. CRA was asked to calculate unit sales dating back decades using historical sales to distributors, census of economic activity, demographic data, and other historical data sources.
Pricing implications for drugs included in China’s Rare Diseases Catalogue (RDC)
China’s Rare Disease Catalogue (RDC) plays a growing role in shaping awareness, investment, and access to therapies for rare diseases in China.